Please login to the form below

Not currently logged in


This page shows the latest daratumumab news and features for those working in and with pharma, biotech and healthcare.

Morphosys’ Darzalex patent challenge hits a hurdle

Morphosys’ Darzalex patent challenge hits a hurdle

Morphosys started its patent infringement claim in 2016, shortly after J&J won approval for anti-CD38 monoclonal antibody Darzalex (daratumumab) in the US as a fourth-line myeloma treatment.  Since

Latest news

More from news
Approximately 8 fully matching, plus 34 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Marketing strategy in complex environments

    Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and

  • ASCO 2015: What you missed in Chicago

    In particular, daratumumab in double refractory multiple myeloma represents a truly transformational treatment in this area for patients who have tried all current options[4]. ... In an area dominated by combination trials, daratumumab showed significant

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....